CN Patent

CN110891575A — 治疗和/或预防光化性角化病的方法

Assigned to Anzix Special Purpose Co ltd · Expires 2020-03-17 · 6y expired

What this patent protects

本申请涉及治疗和/或预防光化性角化病的方法，包括向需要的受试者给予治疗有效量的式(I)的KX‑01。

USPTO Abstract

本申请涉及治疗和/或预防光化性角化病的方法，包括向需要的受试者给予治疗有效量的式(I)的KX‑01。

Drugs covered by this patent

Patent Metadata

Patent number
CN110891575A
Jurisdiction
CN
Classification
—
Expires
2020-03-17
Drug substance claim
No
Drug product claim
No
Assignee
Anzix Special Purpose Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.